Inclusion Criteria:~* Male or female patients between 50 and 85 years of age with a diagnosis of probable
Alzheimers Disease,~* Baseline Mini-Mental State Examination (MMSE) score 10-24 inclusive,~* A primary
caregiver willing to accept responsibility for supervising treatment, assessing the patient's condition
throughout the study, and for providing input into efficacy assessments.~* For double blind only: Meet the
decline criteria of functional (as assessed by the investigator) and cognitive (assessed by a 1 point reduction
in Mini-Mental State Examination) score between visits or a 3 point reduction from baseline) decline at weeks
23, 36 or 48.~
